Skip to content


Volume 11 Supplement 1

Challenges in malaria research

  • Poster presentation
  • Open Access

Sunlight active formulated extract (SAFE): an Egyptian invention for malaria vector control

  • 2 and
  • 1, 2
Malaria Journal201211 (Suppl 1) :P43

  • Published:


  • Malaria
  • Plant Extract
  • Confocal Laser Scan Microscopy
  • Natural Plant
  • Food Additive

This invention introduces an innovative modality for malaria vector control that combines both effectiveness and efficiency with the highest levels of human safety and environment friendliness.

The Novality of this (PCT) patent lies in developing a new ecologically safe modality using a natural plant extract (chlorophyll derivatives) and mosquito larvae attractant as sunlight active photo-larvicide for outdoors control of the larvae of Anopheles gambiae, Culex pipiens and Aedes aegypti. In this context, the accumulated photoactive compound (photosensitizer) in the larvae body induces, upon sunlight exposure, an oxidation stress that results in organism death. The obtained results reveal that SAFE is highly effective as it ensures up to 100% mortality of mosquitoes larvae. The effectiveness of SAFE accumulation in the larvae bodies was qualitatively and quantitatively investigated using the Confocal Laser Scanning Microscopy (CLSM) technique. The active ingredient of SAFE (chlorophyll derivative) exhibit several advantages: they are low cost, natural products extracted from green plants and endorsed by the Food and Drug Administration (FDA) as food additives. In addition, they are used in very low concentrations (µM), can be easily applied in the field by being dissolved in an aquatic environment and most importantly they are highly effective.

Authors’ Affiliations

Faculty of Pharmacy and Biotechnology, German University in Cairo, New Cairo, Egypt
National institute of Laser Enhanced Sciences (NILES), Cairo University, Cairo Egypt


© El-Tayeb and Abdel-Kader; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.